Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.
Sharma S, Galanina N, Guo A, Lee J, Kadri S, Van Slambrouck C, Long B, Wang W, Ming M, Furtado LV, Segal JP, Stock W, Venkataraman G, Tang WJ, Lu P, Wang YL.
Sharma S, et al. Among authors: furtado lv.
Oncotarget. 2016 Oct 18;7(42):68833-68841. doi: 10.18632/oncotarget.11932.
Oncotarget. 2016.
PMID: 27626698
Free PMC article.